Soluble interleukin 2 receptor (sIL-2R) levels in patients with ocular inflammation

被引:0
|
作者
Papadaki, TG
Iaccheri, B
Fiore, T
Androudi, S
Thadani, S
Meniconi, M
Christen, WG
Foster, C
机构
[1] Massachusetts Eye & Ear Infirm, Ocular Immunol & Uveitis Serv, Boston, MA USA
[2] Harvard Univ, Sch Med, Brigham & Womens Hosp, Div Prevent Med,Dept Med, Boston, MA USA
关键词
D O I
暂无
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
4603
引用
收藏
页码:U607 / U607
页数:1
相关论文
共 50 条
  • [41] The role of soluble interleukin-2 (SIL-2R) receptors as a tumor marker in patients with advanced colorectal cancer (ACC)
    Pavlidis, N
    Bairaktari, E
    Nicolaides, C
    KalefEzra, J
    Athanassiadis, A
    Seferiadis, C
    Fountzilas, G
    EUROPEAN JOURNAL OF CANCER, 1995, 31A : 1271 - 1271
  • [42] NEOPTERIN (NPT) AND SOLUBLE INTERLEUKIN 2 RECEPTOR (SIL-2R) AS USEFUL MARKERS OF DISEASE ACTIVITY IN JUVENILE IDIOPATHIC ARTHRITIS (JIA)
    Olesinska, E.
    Postepski, J.
    Tabarkiewicz, J.
    Wilczynska, B.
    Tuszkiewicz-Misztal, E.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 71 : 257 - 258
  • [43] Increased production of interleukin-2 (IL-2) but not soluble interleukin-2 receptors (sIL-2R) in unmedicated patients with schizophrenia and schizophreniform disorder
    ODonnell, MC
    Catts, SV
    Ward, PB
    Liebert, B
    Lloyd, A
    Wakefield, D
    McConaghy, N
    PSYCHIATRY RESEARCH, 1996, 65 (03) : 171 - 178
  • [44] Serum soluble interleukin-2 receptor (sIL-2R) levels in diffuse large B-cell lymphoma (DLBCL): A significant prognostic factor.
    Nakamura, S
    Yokota, A
    Takagi, T
    Yoshino, T
    Niitsu, N
    Sawada, U
    Kodama, F
    Asaoku, H
    Kuraishi, Y
    Okamoto, M
    Yoshida, T
    ANNALS OF ONCOLOGY, 2000, 11 : 103 - 103
  • [45] Soluble interleukin-2 receptors (sIL-2R) in Hodgkin's disease: outcome and clinical implications
    S Viviani
    E Camerini
    V Bonfante
    A Santoro
    M Balzarotti
    M Fornier
    L Devizzi
    P Verderio
    P Valagussa
    G Bonadonna
    British Journal of Cancer, 1998, 77 : 992 - 997
  • [46] Soluble interleukin-2 receptors (sIL-2R) in Hodgkin's disease: outcome and clinical implications
    Viviani, S
    Camerini, E
    Bonfante, V
    Santoro, A
    Balzarotti, M
    Fornier, M
    Devizzi, L
    Verderio, P
    Valagussa, P
    Bonadonna, G
    BRITISH JOURNAL OF CANCER, 1998, 77 (06) : 992 - 997
  • [47] Soluble interleukin-2 receptor (sIL-2R) is a marker of disease activity in psoriasis: A comparison of sIL-2R, sCD27, sCD4, sCD8 and sICAM-1
    deRie, MA
    Zonneveld, IM
    Witkamp, L
    vanLier, RAW
    Out, TA
    Bos, JD
    ACTA DERMATO-VENEREOLOGICA, 1996, 76 (05) : 357 - 360
  • [48] SOLUBLE INTERLEUKIN-2 RECEPTOR (SIL-2R) AND CD8 ANTIGEN (SCD8 AG) LEVELS IN SERA FROM PATIENTS WITH NONRESECTABLE LUNG-CANCER
    VIBEPETERSEN, J
    SORENSEN, HR
    ANDERSEN, V
    SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 1990, 32 (04) : 421 - 421
  • [49] The Role of Soluble Interleukin-2 Receptor (sIL-2r) in Diagnosis of Adult Hemophagocytic Lymphohistiocytosis (HLH): A Single Center Retrospective Study
    Hayden, Anna
    Lin, Molly
    Park, Sujin
    Mattman, Andre
    Pudek, Morris
    Chen, Luke Y. C.
    BLOOD, 2017, 130
  • [50] SOLUBLE INTERLEUKIN-2 RECEPTOR (SIL-2R) MONITORING PROVIDES AN INDICATION OF IMMUNE STATUS IN ADULT LIVER-TRANSPLANT RECIPIENTS
    ROSSI, SJ
    SCHROEDER, TJ
    HANTO, D
    HEPATOLOGY, 1992, 16 (04) : A289 - A289